Annual ROE
-270.67%
-331.45%-545.33%
December 31, 2023
Summary
- As of February 10, 2025, AGE annual return on equity is -270.67%, with the most recent change of -331.45% (-545.33%) on December 31, 2023.
- During the last 3 years, AGE annual ROE has fallen by -483.04% (-227.45%).
Performance
AGE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
92.32%
+27.59%+42.62%
December 31, 2023
Summary
- As of February 10, 2025, AGE quarterly return on equity is 92.32%, with the most recent change of +27.59% (+42.62%) on December 31, 2023.
- Over the past year, AGE quarterly ROE has increased by +19.01% (+25.93%).
Performance
AGE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AGE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -545.3% | +25.9% |
| 3 y3 years | -227.4% | -74.6% |
| 5 y5 years | -198.6% | +191.6% |
AGE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -469.2% | at low | -4.0% | -35.4% |
| 5 y | 5-year | -227.5% | at low | -90.4% | -731.9% |
| alltime | all time | -227.5% | at low | -90.4% | -731.9% |
AgeX Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -270.67%(-545.3%) | 92.32%(+42.6%) |
| Sep 2023 | - | 64.73%(+8.6%) |
| Jun 2023 | - | 59.60%(-11.6%) |
| Mar 2023 | - | 67.45%(-8.0%) |
| Dec 2022 | 60.78%(-17.1%) | 73.31%(-4.5%) |
| Sep 2022 | - | 76.73%(-5.4%) |
| Jun 2022 | - | 81.12%(-9.3%) |
| Mar 2022 | - | 89.43%(-7.0%) |
| Dec 2021 | 73.32% | 96.17%(-21.2%) |
| Sep 2021 | - | 122.09%(-26.2%) |
| Jun 2021 | - | 165.52%(-26.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 226.16%(-37.8%) |
| Dec 2020 | 212.37%(-194.8%) | 363.68%(-62.3%) |
| Sep 2020 | - | 964.47%(-265.3%) |
| Jun 2020 | - | -583.34%(+109.2%) |
| Mar 2020 | - | -278.90%(+38.0%) |
| Dec 2019 | -224.08%(+147.2%) | -202.08%(+11.4%) |
| Sep 2019 | - | -181.36%(+23.0%) |
| Jun 2019 | - | -147.47%(+18.9%) |
| Mar 2019 | - | -124.05%(+23.1%) |
| Dec 2018 | -90.66%(+0.3%) | -100.74% |
| Dec 2017 | -90.38% | - |
FAQ
- What is AgeX Therapeutics annual return on equity?
- What is the all time high annual ROE for AgeX Therapeutics?
- What is AgeX Therapeutics annual ROE year-on-year change?
- What is AgeX Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly ROE year-on-year change?
What is AgeX Therapeutics annual return on equity?
The current annual ROE of AGE is -270.67%
What is the all time high annual ROE for AgeX Therapeutics?
AgeX Therapeutics all-time high annual return on equity is 212.37%
What is AgeX Therapeutics annual ROE year-on-year change?
Over the past year, AGE annual return on equity has changed by -331.45% (-545.33%)
What is AgeX Therapeutics quarterly return on equity?
The current quarterly ROE of AGE is 92.32%
What is the all time high quarterly ROE for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly return on equity is 964.47%
What is AgeX Therapeutics quarterly ROE year-on-year change?
Over the past year, AGE quarterly return on equity has changed by +19.01% (+25.93%)